Drug Delivery Technologies Market, By Route of Administration (Oral, Parenteral (Intramuscular, Intravenous, Intra-Arterial, and Subcutaneous), Nasal Drug Delivery, Ocular Drug Delivery, and Topical/Transdermal), By Therapeutic Area (Oncology, Cardiology, Neurology, Immunology, Rheumatology, Diabetes, and Others (Infectious Diseases, etc.)), By End User (Ambulatory Surgical Clinics, Diagnostic Centers, Hospitals, Homecare Settings, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Dec 2024

Code : CMI2690

Pages :155

Formats :

Excel and PDF

Industry : Medical Devices

Drug Delivery Technologies Market Size and Trends

Global drug delivery technologies market is estimated to be valued at USD 44.10 Bn in 2024 and is expected to reach USD Bn 102.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.7% from 2024 to 2031.

Drug Delivery Technologies Market Key Factors

To learn more about this report, Request sample copy

Advancements in drug delivery systems along with the increasing prevalence of chronic diseases are driving the growth of the market. Various technologies such as oral drug delivery, pulmonary drug delivery, transdermal drug delivery, and others have been enhancing drug delivery capabilities. Targeted drug delivery has been gaining increased focus with the help of nanotechnology which is expected to boost the market growth during the forecast period.

Drug Delivery Technologies Market Concentration By Players

To learn more about this report, Request sample copy

Top Strategies Followed by Global Drug Delivery Technologies Market Players

Established Players: Leading pharmaceutical companies prioritize substantial R&D investments to innovate and enhance drug delivery systems. For instance, in 2022, U.S. firms like Apple , Amazon invested approximately US$ 886 billion in R&D, leveraging technologies like artificial intelligence (AI) to expedite product development and reduce time-to-market
Mid-Level Players: Companies also form technology partnerships to supplement internal capabilities. Partnerships with technology firms and research institutions enhance technological capabilities and market presence. For instance, in January 2024, DelSiTech raised USD 10.58 million to advance its silica-based drug delivery platform, aiming to collaborate with larger entities for broader application.
Small-Scale Players: Small-scale companies often target specific market segments with unique products. For example, Disruptive Pharma develops drug products using proprietary Mesoporous Magnesium carbonate technology, focusing on targeted drug delivery solutions.

Emerging Startups in the Global Drug Delivery Technologies Market

Innovative Technologies: Startups like Anthropic are developing AI-powered smart contact lenses and ingestible sensors to non-invasively monitor health conditions. Others focus on trackable microchip-based implants for controlled drug release directly into organs.

Market/Impact: Such advanced technologies may transform drug delivery via minimal interventions. AI lenses could help diagnose eye diseases prescriptive without eye drops or injections. Implants ensuring direct drug delivery to diseased tissues could significantly improve treatment outcomes.

Market Contribution: Startups address patient needs overlooked by others. BriaCell Therapeutics focuses exclusively on breast cancer immunotherapy while Nabriva focuses on urgent care antibacterials for common infections. Their dedicated approaches fill critical market gaps.